Zimmer Biomet Stock (NYSE:ZBH)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$107.27

52W Range

$101.47 - $133.90

50D Avg

$106.95

200D Avg

$115.41

Market Cap

$21.58B

Avg Vol (3M)

$1.50M

Beta

1.02

Div Yield

$0.96 (0.66%)

ZBH Company Profile


Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

18,000

IPO Date

Jul 25, 2001

Website

ZBH Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Hips$1.97B$1.89B$1.86B
Other Product Category$636.00M$570.00M$595.60M
S E T$1.75B$1.70B$1.73B
Knees$3.04B$2.78B$2.65B
Dental And Spine--$1.01B

Fiscal year ends in Dec 23 | Currency in USD

ZBH Financial Summary


Dec 23Dec 22Dec 21
Revenue$1.94B$6.94B$6.83B
Operating Income$1.26B$1.06B$860.30M
Net Income-$231.40M$401.60M
EBITDA$1.26B$1.99B$1.96B
Basic EPS-$1.39$1.93
Diluted EPS-$1.38$1.91

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Oct 30, 24 | 10:58 AM
Q2 24Aug 07, 24 | 11:58 AM
Q1 24May 02, 24 | 12:00 AM

Peer Comparison


TickerCompany
ABTAbbott Laboratories
BRKRBruker Corporation
OFIXOrthofix Medical Inc.
ITGRInteger Holdings Corporation
LUNGPulmonx Corporation
SYKStryker Corporation
EWEdwards Lifesciences Corporation
SRDXSurmodics, Inc.
MDTMedtronic plc
GKOSGlaukos Corporation
BIOBio-Rad Laboratories, Inc.
CVRXCVRx, Inc.
CNMDCONMED Corporation